Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Improving intradermal drug delivery by highly accurate injection of small volumes in the skin

Latest news

Colli-Pee® Variants

Novosanis launches volume variants of Colli-Pee® offering new applications in urine testing

We are excited to announce the launch of volume variants of Colli-Pee® , our innovative urine-capturing device offering additional applications in the fields of infectious disease, uro-oncology and more.

Latest blogpost

The Japanese challenge: Can urine be the solution in the fight against cervical cancer?
Cervical cancer cases continue to rise in Japan. Learn more about the problem and how urine can offer a solution to facilitate disease detection in our latest blog.

Upcoming event

Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019

Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019

Rotterdam, Netherlands
Novosanis will be present at the Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 conference in Rotterdam, Netherlands.